Centessa’s $38‑Per‑Share Sale to Eli Lilly Sparks Insider Sell‑Off and CVR Upside
Centessa’s sale to Eli Lilly offers $38 per share plus a $9 CVR, sparking a 30 million‑share insider sell‑off and 182 % buzz spike—watch for integration upside.
3 minutes to read